Related Experiment Video

Updated: Jun 16, 2026

Particle Image Velocimetry Investigation of Hemodynamics via Aortic Phantom
06:26

Particle Image Velocimetry Investigation of Hemodynamics via Aortic Phantom

Published on: February 25, 2022

3.6K

HALT and Catch Fire: Understanding the Histopathologic Processes of Hypoattenuated Leaflet Thickening in TAVR

Rahul Gupta1, Matthew W Sherwood2, Amit N Vora1

  • 1Division of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT (R.G., A.N.V.).

Circulation. Cardiovascular Interventions
|February 18, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Editorialsaortic stenosisthrombosistranscatheter aortic valve replacement

More Related Videos

Layer Microdissection of Tricuspid Valve Leaflets for Biaxial Mechanical Characterization and Microstructural Quantification
07:34

Layer Microdissection of Tricuspid Valve Leaflets for Biaxial Mechanical Characterization and Microstructural Quantification

Published on: February 10, 2022

1.7K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

2.6K

Related Experiment Videos

Last Updated: Jun 16, 2026

Particle Image Velocimetry Investigation of Hemodynamics via Aortic Phantom
06:26

Particle Image Velocimetry Investigation of Hemodynamics via Aortic Phantom

Published on: February 25, 2022

3.6K
Layer Microdissection of Tricuspid Valve Leaflets for Biaxial Mechanical Characterization and Microstructural Quantification
07:34

Layer Microdissection of Tricuspid Valve Leaflets for Biaxial Mechanical Characterization and Microstructural Quantification

Published on: February 10, 2022

1.7K
Isolation of Human Primary Valve Cells for In vitro Disease Modeling
07:31

Isolation of Human Primary Valve Cells for In vitro Disease Modeling

Published on: April 16, 2021

2.6K

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...

Articles linked to this work by shared authors, journal, and citation graph.

Linking the TVT Registry to Medicare Advantage and Fee-for-Service Claims: Feasibility, Accuracy, and Implications for Real-World Surveillance Infrastructure.

Circulation. Cardiovascular interventions·2026

Safety review of antithrombotic therapy options after left atrial appendage occlusion.

Expert opinion on drug safety·2025

Rivaroxaban to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease: a narrative review.

Expert opinion on drug safety·2025

A drug safety evaluation of dapagliflozin for diabetic nephropathies in patients with cardiovascular risk.

Expert opinion on drug safety·2025

Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.

Clinical cardiology·2024

An update on the safety of lanreotide autogel for the treatment of patients with neuroendocrine tumors.

Expert opinion on drug safety·2024

One-Year Outcomes of M-TEER With the PASCAL System in Atrial and Ventricular FMR: Insights From the MiCLASP Postmarket Clinical Follow-Up Study.

Circulation. Cardiovascular interventions·2026

Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement.

Circulation. Cardiovascular interventions·2026

Pulmonary Atresia With Intact Septum Survival, Reintervention, and Days in Hospital Through Childhood: Contemporary Outcomes From a National Registry.

Circulation. Cardiovascular interventions·2026

Predictors of Target Lesion Failure in Patients With In-Stent Restenosis: Insights From the AGENT IDE Trial.

Circulation. Cardiovascular interventions·2026

Impact of Coronary Diameter Stenosis and Proximal Lesion Location on Outcomes Following PCI in Patients Undergoing TAVI: Prespecified NOTION-3 Substudy.

Circulation. Cardiovascular interventions·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us